DUBAI, Oct 11 (Reuters) - Bahrain-based investment company GFH Financial Group said on Tuesday it bought its second portfolio of U.S. medical clinics, valued at around $400 million.
China-based Sinopharm has commenced a Phase III clinical trial of its Covid-19 vaccine candidate at the Bahrain International Exhibition and Convention Centre (BIECC).
Bahrain approves new pharmaceuticals factory
Market Place
Share
Bahrain Pharma News Full Screen View
Share
